Emilie Lemaire

Papers

Total Citations

H-Index

About

Emilie Lemaire is a leading urologic oncology researcher whose work centers on optimizing surgical outcomes and quality of life for prostate cancer patients. Her landmark contribution is the LAP-01 trial, a multicenter randomized controlled trial comparing robotic-assisted and laparoscopic radical prostatectomy. This pivotal study, published in 2022 and garnering 19 citations, provides crucial evidence on cross-sectional and longitudinal differences in both general health-related and prostate cancer-specific quality of life following these procedures. Lemaire’s research goes beyond surgical technique, analyzing predictive variables that help clinicians identify which patients are most likely to experience better QoL outcomes. Her work has direct clinical impact, guiding surgeons in patient counseling and shared decision-making. By rigorously evaluating patient-reported outcomes in a randomized setting, Lemaire has advanced the evidence base for minimally invasive prostate cancer surgery, ensuring that treatment decisions are informed not just by oncologic control but by the lived experiences of patients. Her research is essential reading for urologists, surgical oncologists, and researchers focused on patient-centered outcomes in cancer care.